Medication info
Megaset Tablet

Megaset Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
For domestic use - 30 tablets/bottle, for domestic use - 300 tablets/bottle, for domestic use - 100 tablets/PTP [(10T/PTP*10)]
Approval status
Active

MFDS item code 200711209 · Notified 2007.10.09 · Insurance code 645600990

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be spaced at least 6 hours apart, and no more than 8 tablets should be taken per day. Use the lowest effective dose for the shortest possible duration. Do not use this medication for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, regular monitoring should be performed to determine whether treatment with this medication should continue. Elderly patients: The usual adult dose should be administered. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to patients aged 75 years or older, administer this medication at intervals of at least 6 hours. Patients with renal impairment: In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, it is not necessary to administer an additional dose of this medication after dialysis to maintain analgesia. Patients with hepatic impairment: Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medication to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, doses should be spaced at least 6 hours apart, and no more than 8 tablets should be taken per day.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be spaced at least 6 hours apart, and no more than 8 tablets should be taken per day. Use the lowest effective dose for the shortest possible duration. Do not use this medication for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, regular monitoring should be performed to determine whether treatment with this medication should continue. Elderly patients: The usual adult dose should be administered. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to patients aged 75 years or older, administer this medication at intervals of at least 6 hours. Patients with renal impairment: In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, it is not necessary to administer an additional dose of this medication after dialysis to maintain analgesia. Patients with hepatic impairment: Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medication to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, doses should be spaced at least 6 hours apart, and no more than 8 tablets should be taken per day.

Precautions

This medication may pose a risk of liver damage for individuals who regularly consume more than three glasses of alcohol daily; therefore, consultation with a doctor or pharmacist is essential. This medication can rarely cause serious skin reactions, so if skin rash or hypersensitivity occurs, discontinue use immediately. Components in this medication can provoke seizures; caution is particularly warranted for patients with a history of seizures or those taking specific medications concurrently. Rarely, serious allergic reactions such as anaphylaxis may occur, so any unusual symptoms should be reported to medical personnel immediately. This medication may cause respiratory depression in patients with acute and severe bronchial asthma; it should only be used in medical facilities equipped for such emergencies. Taking this medication with alcohol or central nervous system depressants may lead to severe sedation and respiratory depression, so concurrent use should be avoided. Patients with elevated intracranial pressure or head injuries may experience worsened symptoms while using this medication, requiring caution. This medication can lead to psychological and physical dependence, necessitating careful monitoring for signs of dependency during long-term use. Patients with impaired liver function may face worsened liver damage due to the components of this medication, and usage should be discussed with a doctor. Patients with certain genotypes may experience rapid metabolism of this medication, increasing the risk of respiratory depression, thus requiring caution. Children, particularly those under 12 years of age or adolescents under 18 years post-surgery, should not be administered this medication. Patients with sleep apnea may find their symptoms worsen while using this medication, so regular assessments are needed. Elderly patients or those at risk for hyponatremia should monitor for occurrences of hyponatremia while taking this medication. This medication may interact with certain drugs, increasing the risk of seizures or serotonin syndrome, so it is essential to consult healthcare professionals regarding concurrent medications. Pregnant or breastfeeding women should use this medication cautiously, as it may affect the fetus or newborn. This medication may induce drowsiness or dizziness, requiring caution when driving or operating machinery. In cases of overdose, serious respiratory depression, seizures, liver damage, and other severe complications can occur, so it is crucial not to exceed the prescribed dosage. This medication should be kept out of the reach of children, and care should be taken to prevent misuse or abuse.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory loss, tremors, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, sweating, urinary disorders, erectile dysfunction, weakness, chest pain, emotional abnormality, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, warmth, weight loss, increased serum creatinine, anaphylactic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal ideation, muscle tone hyperactivity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, hyponatremia, fixed rash, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, exacerbation of migraine, involuntary muscle contractions, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urinary retention, increased urination, abnormal renal function tests, oliguria, increased rash, urticaria, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, loss of appetite, anxiety, depression, nervousness, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, reduced red blood cells, reduced white blood cells, increased white blood cells, decreased platelets, palpitations, exacerbation of hypertension, arrhythmia, aortic coarctation, gastrointestinal bleeding, elevated cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal visual fields, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, vomiting, dyspepsia, abdominal pain, constipation, dry mouth, diarrhea, dysphagia, flatulence, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, weakness, chest pain, rigidity, syncope, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, upper respiratory syndrome, lip smacking, agitation, nervousness, hyperactivity, panic attacks, severe anxiety, tinnitus, abnormal central nervous system reactions, urticaria, bronchospasm, toxic skin necrosis, allergic reactions, seizures, serotonin syndrome, serotonin syndrome, respiratory suppression, hypoglycemia, high anion gap metabolic acidosis, hyperglutamic acidosis, QT prolongation, hypersomnia, coma, cardiac arrest

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air ingress, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain its effectiveness.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

For domestic use - 30 tablets/bottle, for domestic use - 300 tablets/bottle, for domestic use - 100 tablets/PTP [(10T/PTP*10)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.